Author

Henrik H. Hansen

Gubra (Denmark)ORCID 0000-0002-3732-0281Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Physiology· 2 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Allan Jensen· 1 shared Camilla Stampe JenseniD· 1 shared Casper Graversen SalinasiD· 1 shared Denise Oró· 1 shared Evdoxia Alexiou· 1 shared Florence SottyiD· 1 shared Franziska Wichern· 1 shared Hayley B. BurmiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Allan Jensen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Circulating soluble urokinase-type plasminogen activator receptor reflects disease severity in a mouse model of diabetic kidney disease and heart failure with preserved ejection fraction

Sarah Torp Yttergren, Linn Salto Mamsen, Maria Ougaard, Louise Thisted, Henrik H. Hansen, Urmas Roostalu

The paper evaluates biomarkers in a mouse model of diabetic kidney disease and HFpEF, finding that suPAR levels correlate with disease severity.

bioRxiv · Jul 3, 2026 · PreprintPhysiology

FGF21 deletion mildly exacerbates hepatic dysfunction in MASH diet and alcohol fed rats

Peter Aldiss, Malte Hasle Nielsen, Hayley B. Burm, Denise Oró, Henrik H. Hansen, Michael Feigh, Matthew Paul Gillum

This study shows that FGF21 deletion worsens hepatic dysfunction in rats fed a MASH diet and alcohol, but does not affect body weight or liver transcriptome in the diet model.

npj Metabolic Health and Disease · May 28, 2025Peer-reviewedPhysiology

Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and efficacy of a therapeutic anti-Abeta antibody

Marta Ramos Vega, Henrik H. Hansen, Camilla Stampe Jensen, Evdoxia Alexiou, Martin Rønn Madsen, Franziska Wichern, Jacob Lercke Skytte, Casper Graversen Salinas, Florence Sotty, Allan Jensen, Sandra B. Vergo, Jacob Hecksher‐Sørensen

This study shows that fusing an anti-Aβ antibody to a TfR1-binding Fab fragment enhances brain delivery and plaque clearance while reducing adverse effects in APP/PS1 mice.

bioRxiv · Feb 14, 2025 · PreprintNeuroscience